Public Company News

Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is today pleased to announce that it has been awarded Australian Company of the Year in the 2022 AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards, held today at t...

2022-10-27 10:23 4245

"Time to Kick-Off@ TKO Spot" Seven Football Challenges and DIY Player Card Production Kiosk

* Soak up football vibes from weekend football experiences and score at 5-a-side giant babyfoot game * Eight autographed jerseys on show plus DIY player cards via interactive installation * Multipurpose straps and drawstring bags for redemption via spending during promotion HONG KONG, Oct. ...

2022-10-27 09:01 4242

Appian Announces 2022 APJ Partner Award Winners

Awards announced following strong year of partner ecosystem growth SYDNEY, Oct. 27, 2022 /PRNewswire/ -- Appian (Nasdaq: APPN) announced today its 2022 APJ Partner Award winners across six categories. The awards also celebrate a strong year for Appian's partner ecosystem, with a 120% growth in p...

2022-10-27 09:00 4461

SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM'S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES

SUZHOU,China, Oct. 27, 2022 /PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHARM, Stock code: 1875.HK) has recently received a GMP compliance inspection report approved by aQualified Person ("QP") in the European Union ("EU") in respect of the manufacturing facilities and asso...

2022-10-27 08:00 4557

JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies

* Initial focus on accelerating development of 2seventy's MAGE-A4 program in solid tumors inChina SHANGHAI, China and CAMBRIDGE, Mass., Oct. 27, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and comme...

2022-10-27 07:53 5495

Samsung Biologics Reports Third Quarter 2022 Financial Results

* Recorded consolidated revenue of KRW 873 billion in Q3'22 * Recorded consolidated operating profit of KRW 324.7 billion in Q3'22 * Started partial operations at Plant 4 within 23 months since groundbreaking as previously committed and launched two new development platforms INCHEON, South K...

2022-10-27 07:35 2899

Maxeon Solar Technologies Commences Supplier Sustainability Monitoring with STACS via ESGpedia

SINGAPORE, Oct. 27, 2022 /PRNewswire/ -- Maxeon Solar Technologies ('Maxeon'), a global leader in solar innovation and channels, today announced the commencement of supplier sustainability monitoring withSingapore-headquartered environmental, social, and governance ('ESG') fintech Hashstacs Pte L...

2022-10-27 07:05 3146

Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of TheUniversity of Queensland (UQ), to develop a radiolabelled molecule targeting an im...

2022-10-27 06:44 3848

PINGTAN MARINE ENTERPRISE REPORTS UNAUDITED FINANCIAL RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022

FUZHOU, China, Oct. 26, 2022 /PRNewswire/ -- Pingtan Marine Enterprise Ltd. (Nasdaq: PME) ("Pingtan," "we" or the "Company"), a fishing company based in the People's Republic of China (PRC), today announced the unaudited financial results for the six months endedJune 30, 2022. First Half 2022 Fi...

2022-10-27 04:06 4592

Renren Announces Effectiveness of Settlement Regarding Shareholder Derivative Litigation

PHOENIX, Oct. 26, 2022 /PRNewswire/ -- Renren Inc. (NYSE: RENN) ("Renren" or the "Company"), a SaaS company, today announced that the Final Order and Judgment entered by theNew York State Supreme Court, Commercial Division on June 9, 2022 (the "June 9 Final Order"), which was furnished by the Com...

2022-10-27 04:00 2727

MASERATI AND BARBIE JOIN FORCES FOR AN UNPRECEDENTED COLLABORATION

The House of the Trident unveils a bespoke edition of its latest SUV – Grecale – designed with global icon Barbie MILAN, Oct. 26, 2022 /PRNewswire/ -- Italian luxury icon Maserati is thrilled to unveil an audacious collaboration with Mattel, Inc.'s (NASDAQ: MAT) Barbie®, driven by the mutual des...

2022-10-26 22:30 4986

Waterdrop Opens Its First Community outlet in Shenzhen to Explore the "Insurance + Community" Model

BEIJING, Oct. 26, 2022 /PRNewswire/ -- Waterdrop recently opened its first independent personal insurance agent-based community outlet inShenzhen, which is the first outlet that cooperates with community healthcare centers on insurance service. Critical to Shenzhen's medical service system, comm...

2022-10-26 22:00 3907

Parcel Perform and Quiet Platforms Launch Data Partnership to Enable Supply Chain Visibility for E-Commerce Retailers and Brands

NEW YORK, Oct. 26, 2022 /PRNewswire/ -- Parcel Perform , the leading Data and Delivery Experience Platform for e-commerce businesses worldwide, today announced the launch of a data partnership withQuiet Platforms , a wholly owned s...

2022-10-26 21:00 6121

Lunit Joins World Economic Forum Global Innovators Community

* Lunit invited to join the World Economic Forum's Global Innovators Community, an invitation-only group of the world's most promising start-ups and scale-ups at the forefront of technological and business model innovation * In 2020, Lunit was nominated among hundreds of candidates as one of t...

2022-10-26 21:00 3601

China Natural Resources Receives NASDAQ Minimum Bid Price Requirement Extension

HONG KONG, Oct. 26, 2022 /PRNewswire/ -- China Natural Resources, Inc. (NASDAQ: CHNR) (the "Company"), announced today that onOctober 25, 2022, it received notification from the Nasdaq Capital Market ("Nasdaq") confirming the Company has been granted an additional 180 calendar day period for comp...

2022-10-26 20:46 4144

Ping An Reports Steady Growth of 3.8% in Operating Profit Attributable to Shareholders of Parent Company in 9M 2022

HONG KONG and SHANGHAI, Oct. 26, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) today announced its results for the nine months ended30 September 2022. Global capital markets remained volatile in a complex, chall...

2022-10-26 20:39 4706

Ascletis Announces U.S. IND Filing of Oral Antiviral ASC10 for Monkeypox Indication

--ASC10 has two indications: monkeypox and SARS-CoV-2 virus infections. The Investigational New Drug (IND) application of the latter was approved by the U.S. Food and Drug Administration (FDA) inAugust 2022 and Phase Ib clinical trial in COVID-19 patients is underway in the U.S. --Preclinical st...

2022-10-26 20:10 3935

Follow-on High-Volume Farmmi Order to Ship to the Middle East

LISHUI, China, Oct. 26, 2022 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agricultural products supplier inChina, today announced a follow-on high-volume order, which will ship to theMiddle East. The latest order comes from one of Farmmi's long-term customers and is...

2022-10-26 20:00 2608

Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting

MELBOURNE, Australia and SAN FRANCISCO , Oct. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation f...

2022-10-26 19:25 3311

WuXi AppTec Reports Record Year-to-Date Results in 2022, Third Quarter Revenue over RMB10 Billion

Revenue Up 71.9% Year-Over-Year to RMB28,395 Million Net Profit Attributable to Owners of the Company Up 107.1% Year-Over-Year to RMB7,378 Million Diluted Earnings Per Share (EPS) Up 90.1% Year-Over-Year to RMB2.30 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 77.9% Year...

2022-10-26 19:06 4475